Novel Use of Proton Magnetic Resonance Spectroscopy (1HMRS) to Non-Invasively Assess Placental Metabolism
Open Access
- 10 August 2012
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 7 (8) , e42926
Abstract
Placental insufficiency is a major cause of antepartum stillbirth and fetal growth restriction (FGR). In affected pregnancies, delivery is expedited when the risks of ongoing pregnancy outweigh those of prematurity. Current tests are unable to assess placental function and determine optimal timing for delivery. An accurate, non-invasive test that clearly defines the failing placenta would address a major unmet clinical need. Proton magnetic resonance spectroscopy (1H MRS) can be used to assess the metabolic profile of tissue in-vivo. In FGR pregnancies, a reduction in N-acetylaspartate (NAA)/choline ratio and detection of lactate methyl are emerging as biomarkers of impaired neuronal metabolism and fetal hypoxia, respectively. However, fetal brain hypoxia is a late and sometimes fatal event in placental compromise, limiting clinical utility of brain 1H MRS to prevent stillbirth. We hypothesised that abnormal placental 1H MRS may be an earlier biomarker of intrauterine hypoxia, affording the opportunity to optimise timing of delivery in at-risk fetuses. We recruited three women with severe placental insufficiency/FGR and three matched controls. Using a 3T MR system and a combination of phased-array coils, a 20×20×40 mm1H MRS voxel was selected along the ‘long-axis’ of the placenta with saturation bands placed around the voxel to prevent contaminant signals. A significant choline peak (choline/lipid ratio 1.35–1.79) was detected in all healthy placentae. In contrast, in pregnancies complicated by FGR, the choline/lipid ratio was ≤0.02 in all placentae, despite preservation of the lipid peak (p1H MRS may represent an early biomarker of critical placental insufficiency. Further studies will determine performance of this test and the potential role of 1H-MRS in the in-vivo assessment of placental function to inform timing of delivery.Keywords
This publication has 35 references indexed in Scilit:
- Magnetic resonance imaging relaxation time measurements of the placenta at 1.5 TPlacenta, 2011
- Intra-uterine growth restriction is associated with increased apoptosis and altered expression of proteins in the p53 pathway in villous trophoblastApoptosis, 2010
- Noninvasive Monitoring of Placental Oxygenation by Near-Infrared SpectroscopyAmerican Journal of Perinatology, 2010
- Evaluation of placental function using near infrared spectroscopy during fetal growth restrictionJournal of Perinatal Medicine, 2010
- Transabdominal Measurement of Placental Oxygenation by Near-infrared SpectroscopyAmerican Journal of Perinatology, 2009
- The Cost of Preterm Birth Throughout Childhood in England and WalesPediatrics, 2009
- Analysis of the Metabolic Footprint and Tissue Metabolome of Placental Villous Explants Cultured at Different Oxygen Tensions Reveals Novel Redox BiomarkersPlacenta, 2008
- Centile charts for birthweight for gestational age for Scottish singleton birthsBMC Pregnancy and Childbirth, 2008
- Proton magnetic resonance spectroscopy in neuroblastoma: Current status, prospects and limitationsCancer Letters, 2005
- Structural analysis of placental terminal villi from growth-restricted pregnancies with abnormal umbilical artery doppler waveformsPlacenta, 1996